A FinnGen pilot clinical recall study for Alzheimer’s disease

A FinnGen pilot clinical recall study for Alzheimer’s disease

Abstract Successful development of novel therapies requires that clinical trials are conducted in patient cohorts with the highest benefit-to-risk ratio. Population-based biobanks with comprehensive health and genetic data from large numbers of individuals hold promise to facilitate identification o...

Full description

Bibliographic Details
Main Authors: Valtteri Julkunen, Claudia Schwarz, Juho Kalapudas, Merja Hallikainen, Aino-Kaisa Piironen, Arto Mannermaa, Hanna Kujala, Timo Laitinen, Veli-Matti Kosma, Teemu I. Paajanen, Reetta Kälviäinen, Mikko Hiltunen, Sanna-Kaisa Herukka, Sari Kärkkäinen, Tarja Kokkola, Mia Urjansson, FinnGen, Markus Perola, Aarno Palotie, Eero Vuoksimaa, Heiko Runz
Format: Article
Language:English
Published: Nature Portfolio 2023-08-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-023-39835-7

Internet

https://doi.org/10.1038/s41598-023-39835-7

Similar Items